Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet
Marketer
Danavish Healthcare
Salt Composition
Telmisartan (40mg) + Chlorthalidone (12.5mg)
Overview Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet
Telmisartan and Chlorthalidone 40mg/12.5mg tablets (Danavish) combine two active ingredients to effectively manage hypertension. This dual action reduces the long-term risk of stroke and heart attack. Danavish may be taken with or without food, at the same time daily, and dosage is personalized based on individual response. Continuous use, as directed by your physician, is crucial; discontinuation increases cardiovascular risk. The medication includes a diuretic, promoting increased urination, thus best avoided within four hours of bedtime. Consistent use is vital for optimal benefit, even during asymptomatic periods, as hypertension often lacks noticeable symptoms. Dizziness is a common side effect; others include nausea, diarrhea, headache, and altered cholesterol levels. Increased urination is a known effect of the diuretic component and contributes to blood pressure control. While other adverse effects are possible, they are infrequent. Always consult the patient information leaflet and report any persistent or troublesome side effects to your doctor; dosage adjustment or alternative treatment may be considered. This medication is unsuitable during pregnancy and requires prior consultation with your doctor if you have kidney, liver, or heart conditions, or diabetes. Alcohol consumption should be limited due to its potential to further reduce blood pressure and exacerbate side effects.
Primary Ingredients of Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet
No text was provided. Please provide the text you wish me to rewrite.
Uses of Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Danavish Telmisartan+Chlorthalidone 40mg/12.5mg tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
Common Side effects of Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet:
- Dizziness
- Back pain
- Sinus infection
- Diarrhea
- Red spots or bumps
- Decreased potassium level in blood
- Increased uric acid level in blood
- Postural hypertension (high blood pressure)
- Impotence
- Loss of appetite
- Gastrointestinal disturbance
How to use Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent daily timing is recommended.
How Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet works:
Telmisartan and chlorthalidone, combined at 40mg/12.5mg per tablet in Danavish, offer a dual-action approach to managing certain health conditions.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Danavish Telmisartan+Chlorthalidone 40mg/12.5mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Danavish Telmisartan+Chlorthalidone 40mg/12.5mg tablets during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Danavish Telmisartan+Chlorthalidone 40mg/12.5mg tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking Danavish Telmisartan+Chlorthalidone 40mg/12.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with severe kidney impairment should use Telmisartan/Chlorthalidone 40mg/12.5mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. This medication is generally not recommended for patients with such conditions.
LiverCAUTION
Patients with liver impairment should use Telmisartan/Chlorthalidone 40mg/12.5mg tablets cautiously, potentially requiring dosage modification. Severe liver disease contraindicates the use of this medication; physician consultation is advised.
What if you forget to take Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet :
Should you forget to take your Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Danavish Telmisartan+Chlorthalidone 40mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |


